Breyer Capital Expands Healthcare & Life Sciences Team With Appointment of Dr. Bret Bostwick as Venture Advisor [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
AUSTIN, Texas, December 19, 2025 BUSINESS WIRE Breyer Capital , a premier venture capital investor focused on backing high-impact entrepreneurs, today announced the appointment of Dr. Bret Bostwick as Venture Advisor. Dr. Bostwick will work closely with Dr. Morgan Cheatham , Partner and Head of Healthcare & Life Sciences at Breyer Capital, who leads the firm's investment strategy in the sector, and with Founder and CEO Jim Breyer . Together, they will continue to build an integrated healthcare and life sciences investment platform spanning drug discovery through care delivery. In this role, Dr. Bostwick will strengthen investment, incubation, and portfolio efforts across therapeutics and life sciences, contributing translational and clinical judgment to Breyer Capital's healthcare and life sciences practice. Dr. Bostwick is a physician-scientist and drug developer with senior leadership experience across translational medicine, drug discovery, and clinical development. Building on
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Alnylam's Manufacturing Expansion and Extra-Hepatic RNAi Delivery Could Be A Game Changer For Alnylam Pharmaceuticals (ALNY) [Yahoo! Finance]Yahoo! Finance
- PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues [Yahoo! Finance]Yahoo! Finance
- Alnylam plans $250m investment in Norton manufacturing facility, US [Yahoo! Finance]Yahoo! Finance
- Cambridge biotech will invest $250M in Mass. production facility, add jobs [Yahoo! Finance]Yahoo! Finance
- Alnylam to Invest $250 Million to Add Enzymatic Ligation Platform to U.S. Manufacturing Facility to Meet Growing Global Demand for RNAi Therapeutics [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 10/30/25 - Beat
ALNY
Sec Filings
- 12/11/25 - Form 8-K
- 12/3/25 - Form 8-K
- 12/1/25 - Form 4
- ALNY's page on the SEC website